2020
DOI: 10.3390/genes11101193
|View full text |Cite
|
Sign up to set email alerts
|

Campylobacter jejuni Cas9 Modulates the Transcriptome in Caco-2 Intestinal Epithelial Cells

Abstract: The zoonotic human pathogen Campylobacter jejuni is known for its ability to induce DNA-damage and cell death pathology in humans. The molecular mechanism behind this phenomenon involves nuclear translocation by Cas9, a nuclease in C. jejuni (CjeCas9) that is the molecular marker of the Type II CRISPR-Cas system. However, it is unknown via which cellular pathways CjeCas9 drives human intestinal epithelial cells into cell death. Here, we show that CjeCas9 released by C. jejuni during the infection of Caco-2 hum… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 58 publications
1
7
0
Order By: Relevance
“…We have previously shown that ~98 % of all C. jejuni genomes have a CRISPR-Cas system, while this is more limited in C. coli, where only ~10 % of C. coli genomes have a CRISPR-Cas system [34]. Since the diversity in CRISPR spacers is also low in the chromosomal version of CRISPR-Cas of C. jejuni and C. coli and most spacers cannot (yet) be linked to mobile elements or phages [34,[59][60][61], the chromosomal copy of Cas9 may perform additional or alternative functions in C. jejuni, such as control or activity in virulence [62][63][64][65][66]. However, this is not the case for the CampyICE1 CRISPR-Cas9 system, as a majority of spacers can be linked to the three main families of plasmids in C. jejuni and C. coli: pTet, pVir and pCC42.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…We have previously shown that ~98 % of all C. jejuni genomes have a CRISPR-Cas system, while this is more limited in C. coli, where only ~10 % of C. coli genomes have a CRISPR-Cas system [34]. Since the diversity in CRISPR spacers is also low in the chromosomal version of CRISPR-Cas of C. jejuni and C. coli and most spacers cannot (yet) be linked to mobile elements or phages [34,[59][60][61], the chromosomal copy of Cas9 may perform additional or alternative functions in C. jejuni, such as control or activity in virulence [62][63][64][65][66]. However, this is not the case for the CampyICE1 CRISPR-Cas9 system, as a majority of spacers can be linked to the three main families of plasmids in C. jejuni and C. coli: pTet, pVir and pCC42.…”
Section: Discussionmentioning
confidence: 99%
“…coli and most spacers cannot (yet) be linked to mobile elements or phages [34, 59–61], the chromosomal copy of Cas9 may perform additional or alternative functions in C. jejuni , such as control or activity in virulence [62–66]. However, this is not the case for the CampyICE1 CRISPR-Cas9 system, as a majority of spacers can be linked to the three main families of plasmids in C.…”
Section: Discussionmentioning
confidence: 99%
“…We have previously shown that ~98% of all C. jejuni genomes have a CRISPR-Cas system, while this is more limited in C. coli, where only ~10% of C. coli genomes have a CRISPR-Cas system [34]. Since the diversity in CRISPR spacers is also low in the chromosomal version of CRISPR-Cas of C. jejuni and C. coli and most spacers cannot (yet) be linked to mobile elements or phages [34,[57][58][59], it may represent additional or alternative functions for Cas9 in C. jejuni, such as control or activity in virulence [60][61][62][63][64]. However, this is not the case for the CampyICE1 CRISPR-Cas9 system, as a majority of spacers can be linked to the three main families of plasmids in C. jejuni and C. coli: pTet, pVir and pCC42.…”
Section: Discussionmentioning
confidence: 99%
“…The S. pyogenes mechanism involves Cas9-mediated down-regulation of the FasA/FasB TCS that downregulates adhesion factors ( Gao et al., 2019 ). Campylobacter jejuni and S. agalactiae Cas9s can increase bacterial cytotoxicity, adhesion, and survival within hosts cells ( Louwen et al., 2013 ; Ma et al., 2018 ; Shabbir et al., 2018 ; Saha et al., 2020a ). In S. agalactiae , hyaluronidase activity essential for blood-brain barrier penetration is regulated via Cas9-mediated cleavage of the master regulator regR transcript ( Figure 1B , ( Ma et al., 2018 )).…”
Section: Physiological Roles Of Crispr-cas Observed In Bacteriamentioning
confidence: 99%